Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology.

Valdagni, Riccardo;Van Poppel, Hendrik;Aitchison, Michael;Albers, Peter;Costa, Alberto;et.al.
(2015) Critical Reviews in Oncology / Hematology — Vol. 95, n° 2, p. 133-143 (2015)

Files

Valdagni-2015-Prostatecancerunitinitiativeineurope.pdf
  • Restricted Access
  • Adobe PDF
  • 495.11 KB

Details

Authors
  • Valdagni, Riccardo
    Author
  • Van Poppel, Hendrik
    Author
  • Aitchison, Michael
    Author
  • Albers, Peter
    Author
  • Author
  • Costa, Alberto
    Author
Show more
Abstract
The Prostate Cancer Programme of the European School of Oncology developed the concept of specialised interdisciplinary and multiprofessional prostate cancer care to be formalized in Prostate Cancer Units (PCU). After the publication in 2011 of the collaborative article "The Requirements of a Specialist Prostate Cancer Unit: A Discussion Paper from the European School of Oncology", in 2012 the PCU Initiative in Europe was launched. A multiprofessional Task Force of internationally recognized opinion leaders, among whom representatives of scientific societies, and patient advocates gathered to set standards for quality comprehensive prostate cancer care and designate care pathways in PCUs. The result was a consensus on 40 mandatory and recommended standards and items, covering several macro-areas, from general requirements to personnel to organization and case management. This position paper describes the relevant, feasible and applicable core criteria for defining PCUs in most European countries delivered by PCU Initiative in Europe Task Force.
Affiliations

Citations

Valdagni, R., Van Poppel, H., Aitchison, M., Albers, P., Berthold, D., Bossi, A., Brausi, M., Denis, L., Drudge-Coates, L., De Santis, M., Feick, G., Harrison, C., Haustermans, K., Hollywood, D., Hoyer, M., Hummel, H., Mason, M., Mirone, V., Müller, S. C., et al. (2015). Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology. Critical Reviews in Oncology / Hematology, 95(2), 133-143. https://doi.org/10.1016/j.critrevonc.2015.05.014 (Original work published 2015)